ArticleBrain & spine2022

Predicting survival of patients with spinal metastatic disease using PathFx 3.0 - A validation study of 668 patients in Sweden.

Christian Carrwik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.